AZB & Partners and Quillon Partners advised on Rubicon Research’s acquisition of 85% stake in Arinna Lifesciences.
Rubicon Research Limited has acquired an 85% stake in Arinna Lifesciences Limited, marking Rubicon’s entry into the Indian domestic formulations market.
AZB & Partners represented Rubicon Research Limited on the acquisition.
The deal team comprised Senior Partner Anand Shah, Partner Shriram Shah, Senior Associate Gokul Gopakumar, and Associates Jhanvi Sangani and Namit Vora, with support on CCI analysis from Senior Partner Bharat V. Budholia and Associate Anmol Awasthi.
Quillon Partners advised Motilal Oswal Alternates and other shareholders of Arinna Lifesciences Limited on the sale of their shareholding to Rubicon Research Limited.
The team comprised Ankit Majmudar, Sunandan Majumdar, Abhimanyu Sharma, Abhishek Jain and Ritik Khatri.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
